O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
about
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanomaAccumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects.Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC and fotemustine chemotherapy.Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantationO6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in micePhase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours.Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line.O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma.Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine.Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell levelDosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells.
P2860
Q33346613-0B70CD47-DB97-4DAC-A18F-D929B8CB64B4Q33494887-0DC16105-CAB2-442B-8023-06EE1E3FEC8AQ35031610-D2741065-E9CF-484D-9A9A-2892E64B3CB6Q35686954-A10EF4F1-4564-4DDA-B4A9-CC8CFC5472E6Q35978302-DF5008BB-275D-4DB3-85A1-3C6B0D8185FCQ35978464-815B21D2-8C19-4CC5-A2EF-934AE736430EQ35994192-88F209D5-E77D-49FE-914F-E22D6297E6C6Q36115025-6AF25739-EED0-45AF-8147-DE0235DD917CQ36619026-A0D98155-66A7-40C5-8DDC-EC19769EC582Q36620866-3EAC8DDF-40E3-4ED7-897E-01D20E1C7F58Q36644575-18B65BE6-7846-461F-AB88-F1C21318E693Q37121130-634BCC4D-EA8E-4A0D-B56D-8B64114A8DD8Q37355401-AF7AA7C5-7CF2-4BAB-8457-1CAF6B267BB6Q39992361-A6B9FCCE-C8D5-4E9B-AC7E-F658CD6C1577Q39993380-49400890-AF16-4875-A9A5-9018D87E1F10Q40069172-A9027408-393B-4C52-9256-8F70B900FF19Q41548366-6E586C55-51D3-4805-84FA-F8FAFA37BC07Q41610272-A8532488-C205-4630-A96A-2588CC3A5946Q42046696-C32E0E40-E251-4E61-A7D2-4575BC17B8B3Q42389408-F1D30DC8-DC18-40FF-A97E-0A36AC129B0DQ42390557-9A7DB6C3-02CA-43EB-AFDF-9D033AE183C5
P2860
O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@en
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@nl
type
label
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@en
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@nl
prefLabel
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@en
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@nl
P2093
P1433
P1476
O6-alkylguanine-DNA alkyltrans ...... g dacarbazine and fotemustine.
@en
P2093
P304
P407
P577
1991-01-01T00:00:00Z